Medicare Enrolled

Dr. Mark Swierzewski, M.D.

Urology Physician · Lakeland, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1600 LAKELAND HILLS BLVD, Lakeland, FL 33805
8636807300
In practice since 2006 (19 years)
NPI: 1497705727 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Swierzewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swierzewski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Swierzewski

Dr. Mark Swierzewski is an urology physician in Lakeland, FL, with 19 years in practice. Based on federal Medicare data, Dr. Swierzewski performed 3,489 Medicare services across 2,516 unique beneficiaries.

Between the years covered by Open Payments, Dr. Swierzewski received a total of $1,724 from 24 pharmaceutical and/or device companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Swierzewski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 31% volume in FL$ $1,724 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,489
Medicare services
Top 31% in FL for urology physician
2,516
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~184 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)775$66$132
Office visit, established patient (30-39 min)499$92$194
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant355$41$161
Diagnostic exam of bladder and urethra using an endoscope352$182$414
Automated urinalysis279$2$8
Injection, garamycin, gentamicin, up to 80 mg143$2$5
Bladder ultrasound after voiding131$8$48
New patient office visit (45-59 min)118$119$299
Crushing of stone of ureter with insertion of stent using an endoscope67$340$1,191
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope60$248$795
New patient office visit (30-44 min)60$76$197
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant59$161$602
Simple insertion of temporary bladder tube53$46$158
Insertion of stent in ureter using an endoscope53$116$2,145
Ultrasound scan of pelvic region through rectum49$104$355
Drug injection, under skin or into muscle49$9$50
Biopsy of prostate gland47$162$625
Simple bladder irrigation and/or instillation42$59$210
Professional service for single injection of allergen37$8$24
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope33$567$2,214
Allergy injection therapy, multiple injections29$9$30
Shock wave crushing of kidney stones27$457$1,482
Electronic assessment of bladder emptying27$6$155
Office visit, established patient (10-19 min)27$33$79
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm19$217$760
Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope18$206$797
Crushing of stone of ureter using an endoscope18$304$1,089
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional18$17$36
Removal or manipulation of stone in ureter or kidney using an endoscope17$310$1,096
Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm14$191$648
Destruction and/or removal of large growth of bladder using an endoscope14$295$1,032
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.2% high complexity
13.9% medium
80.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,724
Total received (2018-2024)
Avg $246/year across 7 years
Bottom 33% in FL for urology physician
24
Companies
62
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,609 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (6.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$219
2023
$178
2022
$206
2021
$401
2020
$249
2019
$293
2018
$176

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$506
COLOPLAST CORP
$192
Astellas Pharma US Inc
$184
Medtronic, Inc.
$159
Stability Biologics, LLC
$113
Boston Scientific Corporation
$75
Teleflex LLC
$66
Endo Pharmaceuticals Inc.
$63
Endo USA, Inc.
$50
BOSTON SCIENTIFIC CORPORATION
$46
Hollister Incorporated
$39
Olympus America Inc.
$30
180 Medical, Inc.
$27
TOLMAR Pharmaceuticals, Inc.
$23
PROCEPT BioRobotics Corporation
$22
NeoTract Inc.
$20
Antares Pharma, Inc.
$18
Medtronic USA, Inc.
$15
DENTSPLY IH AB
$15
Amgen Inc.
$14
DENTSPLY IH Inc.
$13
PFIZER INC.
$12
UroGen Pharma, Inc.
$12
Janssen Biotech, Inc.
$11
Top 3 companies account for 51.2% of total payments
Associated products mentioned in payments ›
ALTIS · AMS · AQUABEAM SYSTEM · CONTINENCE CARE · ELIGARD · Erleada · GENERAL THERAPIES · INTERSTIM · JELMYTO · LithoVue · LoFric · MYRBETRIQ · Myrbetriq · NOCDURNA · PREMARIN · Prolia · REZUM · SpeediCath · TITAN · UROLIFT · UroLift · VaPro · VaPro Plus Pocket · XIAFLEX · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $49 per 100 Medicare services performed
Looking for a urology physician in Lakeland?
Compare urology physicians in the Lakeland area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
47
Per 100K population
6.2
County median income
$63,644
Nearest hospital
LAKELAND REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Swierzewski is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Swierzewski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Swierzewski performed 775 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Swierzewski receive payments from pharmaceutical companies?
Yes. Dr. Swierzewski received a total of $1,724 from 24 companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swierzewski's costs compare to other urology physicians in Lakeland?
Dr. Swierzewski's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swierzewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →